Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Invested Capital (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Return on Invested Capital for 12 consecutive years, with 0.05% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 4.0% year-over-year to 0.05%, compared with a TTM value of 0.05% through Oct 2025, up 4.0%, and an annual FY2025 reading of 0.05%, up 4.0% over the prior year.
  • Return on Invested Capital was 0.05% for Q4 2025 at Pharma-Bio Serv, down from 0.05% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.08% in Q1 2021 and bottomed at 0.25% in Q3 2022.
  • Average Return on Invested Capital over 5 years is 0.04%, with a median of 0.05% recorded in 2025.
  • The sharpest move saw Return on Invested Capital plummeted -31bps in 2022, then soared 31bps in 2023.
  • Year by year, Return on Invested Capital stood at 0.2% in 2021, then fell by -24bps to 0.25% in 2022, then surged by 121bps to 0.05% in 2023, then tumbled by -285bps to 0.1% in 2024, then skyrocketed by 44bps to 0.05% in 2025.
  • Business Quant data shows Return on Invested Capital for PBSV at 0.05% in Q4 2025, 0.05% in Q3 2025, and 0.06% in Q2 2025.